Filter

1,001-1,010 of 1,031 results

  • Most State Medicaid Programs Intend to Keep Pandemic-Era Expansions in Telehealth for Behavioral Health Services and Are Adopting Strategies to Address Workforce Shortages in Behavioral Health

    News Release

    Two new KFF analyses examine how state Medicaid programs have utilized telehealth to increase access to behavioral health care during the pandemic and the strategies they are employing to address workforce shortages in behavioral health. The studies come as the 2022 Bipartisan Safer Communities Act legislation requires the federal government to issue telehealth guidance by the end of 2023, and the omnibus spending bill that Congress passed last month included several provisions affecting behavioral health…

  • What Do the Early Medicaid Unwinding Data Tell Us?

    Policy Watch

    As states begin to unwind the COVID emergency continuous enrollment provision and resume Medicaid disenrollments, early data from a handful of states – highlighted on KFF’s regularly-updated Medicaid Enrollment and Unwinding Tracker -- reveal wide variation in disenrollment rates.

  • 4 Key Q&As About the Impact of Climate Change on Health Equity

    News Release

    While climate change effects ripple across the world and all populations, it is poised to disproportionately affect people of color, low-income communities, immigrants, and other high-need groups. Many of these groups have historically been exposed to climate hazards due to government policies and discriminatory practices that leave them more vulnerable to adverse climate events like record-breaking heat, wildfires, coastal flooding, and the spread of infectious diseases. A new KFF brief looks at key questions about…

  • Medication Abortion in the Courts: What’s at Stake?

    News Release

    Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000, has a long record of safety and effectiveness and has been used by more than 5 million people in the United States. In the most…

  • Five Key Findings on Mental Health and Substance Use Disorders by Race/Ethnicity

    Issue Brief

    Rapidly rising rates of deaths by suicide and drug overdose among people of color, along with disproportionate impacts of the COVID-19 pandemic, further underscore inequities in access to mental health care and treatment and highlight the importance of centering equity in diagnostics, care, and treatment.

  • Tapping Nurse Practitioners to Meet Rising Demand for Primary Care

    Issue Brief

    More than 58 million Americans, or nearly 1 in 5, live in primary care shortage areas, where the supply of primary care physicians is not sufficient to meet the needs of the population. Particularly as the demand for primary care increases due to population growth, aging, and expanded insurance coverage, strategies to mitigate already sharp strains on primary care capacity are needed. This brief focuses on the opportunity to more fully tap the potential of…

  • Federal and State Standards for “Essential Community Providers” under the ACA and Implications for Women’s Health

    Issue Brief

    Safety net providers such as community health centers and family planning clinics have served a significant role in the provision of primary care and reproductive health care services to low-income and uninsured people, particularly women. The Affordable Care Act (ACA) has a provision aimed at assuring that newly-insured individuals, as well as those without coverage, can continue seeing their trusted safety net providers, also called Essential Community Providers (ECPs). This brief reviews the definition of…